GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

"First, I eat far less. That seems to be what everyone on Wegovy does. Second, I eat totally different things vs before," ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.

Daniel Drucker, the Canadian scientist renowned for discoveries that sparked the advent of Ozempic and other GLP-1 medicines ...

chief scientific advisor at Novo Nordisk. “It feels wonderful to be recognized, not just for me personally, but for all my co-workers and trainees throughout my career,” Drucker said. “For a physician ...

China is refusing to back down after being hit with a 104% tariff from Trump last night, responding with an 84% tariff rate ...

We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to ...

It’s a bigger deal than any deal announced in 2024 ... the dealmaking environment from a regulatory perspective." Novo Nordisk’s global head of business development and M&A, John MacDonald ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...